Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 2Other hematologic neoplasm 1Lymphoid 1Breast 1

Conditions

Meningeal Neoplasms 1Meningeal Carcinomatosis 1Lymphoma 1Leukemia 1Brain Neoplasms 1

Interventions

Methylphenidate 2Methods 2sargramostim 1ropidoxuridine 1entrectinib 1entinostat 1cc-486 1carboxyamido-triazole 1bintrafusp alfa protein, human 1Watchful Waiting 1WP 744 1Vincristine 1Thalidomide 1Temozolomide 1Ritonavir 1Radiotherapy 1Quality of Life 1Psychology, Positive 1Psychiatric Rehabilitation 1Pemetrexed 1Patient Reported Outcome Measures 1Paclitaxel 1Observation 1O(6)-benzylguanine 1N-(2,3-dihydroxypropyl)-1-((2-fluoro-4-iodophenyl)amino)isonicotinamide 1Molecular Diagnostic Techniques 1Megestrol Acetate 1Magnetic Resonance Spectroscopy 1Interviews as Topic 1Injections 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Brain Neoplasms × WP 744 × Other hematologic neoplasm × Clear all
NCT00512460 2016-05-16

RTA 744 Injection in Patients With Leptomeningeal Disease

M.D. Anderson Cancer Center

Phase 1 Terminated
7 enrolled
CNSLymphoidOther hematologic neoplasm

Brain Neoplasms, Leukemia, Lymphoma, Meningeal Neoplasms, Meningeal Carcinomatosis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡